X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

BYSI

Closed

Beyondspring Inc

2.42
+0.07 (+2.98%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.35
Day's Range: 2.385 - 2.5
Send
When Written:
 
1.12
BeyondSpring Inc is a clinical-stage biopharmaceutical company focused on the development of innovative cancer therapies. The company's lead product candidate, Plinabulin, is a small molecule that has shown promising results in preclinical and clinical studies for the treatment of various types of cancer, including lung cancer, breast cancer, and ovarian cancer. BeyondSpring is also developing other novel cancer therapies, including immuno-oncology agents and targeted therapies. The company is headquartered in New York City and has research and development facilities in Maryland and Shanghai, China. BeyondSpring went public in 2017 and is listed on the NASDAQ stock exchange under the ticker symbol BYSI.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X